Risselada AP - Search Results

1

Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab.

van Assen S, Holvast A, Benne CA, Posthumus MD, van Leeuwen MA, Voskuyl AE, Blom M, Risselada AP, de Haan A, Westra J, Kallenberg CG, Bijl M. van Assen S, et al. Among authors: risselada ap. Arthritis Rheum. 2010 Jan;62(1):75-81. doi: 10.1002/art.25033. Arthritis Rheum. 2010. PMID: 20039396 Free article.

2

Treatment of refractory SLE with rituximab plus cyclophosphamide: clinical effects, serological changes, and predictors of response.

Jónsdóttir T, Gunnarsson I, Risselada A, Henriksson EW, Klareskog L, van Vollenhoven RF. Jónsdóttir T, et al. Ann Rheum Dis. 2008 Mar;67(3):330-4. doi: 10.1136/ard.2007.079095. Epub 2007 Sep 7. Ann Rheum Dis. 2008. PMID: 17827182 Clinical Trial.

3

Costs of rituximab maintenance treatment in patients with refractory rheumatoid arthritis.

Risselada A, Tekstra J, Teng YK, Welsing PM, Breedveld F, van Laar JM, Bijlsma JW. Risselada A, et al. Ann Rheum Dis. 2010 Oct;69(10):1891-2. doi: 10.1136/ard.2009.126029. Epub 2010 May 5. Ann Rheum Dis. 2010. PMID: 20444758 No abstract available.

4

Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE.

Vallerskog T, Gunnarsson I, Widhe M, Risselada A, Klareskog L, van Vollenhoven R, Malmström V, Trollmo C. Vallerskog T, et al. Clin Immunol. 2007 Jan;122(1):62-74. doi: 10.1016/j.clim.2006.08.016. Epub 2006 Oct 13. Clin Immunol. 2007. PMID: 17046329 Clinical Trial.

5

Therapy-resistent lupus skin disease successfully treated with rituximab.

Risselada AP, Kallenberg CG. Risselada AP, et al. Rheumatology (Oxford). 2006 Jul;45(7):915-6. doi: 10.1093/rheumatology/kel162. Epub 2006 May 11. Rheumatology (Oxford). 2006. PMID: 16690759 No abstract available.

6

Stabilization of oral anticoagulant therapy in hospitalized patients and characteristics associated with lack of stabilization.

van den Bemt PM, Joosten P, Risselada A, van den Boogaart MH, Egberts AC, Brouwers JR. van den Bemt PM, et al. Pharm World Sci. 2000 Aug;22(4):147-51. doi: 10.1023/a:1008738732140. Pharm World Sci. 2000. PMID: 11103385

7

The potential interaction between oral anticoagulants and acetaminophen in everyday practice.

van den Bemt PM, Geven LM, Kuitert NA, Risselada A, Brouwers JR. van den Bemt PM, et al. Pharm World Sci. 2002 Oct;24(5):201-4. doi: 10.1023/a:1020555321857. Pharm World Sci. 2002. PMID: 12426965

8

High soluble IL-7 receptor expression in Sjögren's syndrome identifies patients with increased immunopathology and dryness.

Hillen MR, Blokland SL, Risselada AP, Bikker A, Lauwerys BR, Kruize AA, Radstake TR, van Roon JA. Hillen MR, et al. Among authors: risselada ap. Ann Rheum Dis. 2016 Sep;75(9):1735-6. doi: 10.1136/annrheumdis-2016-209236. Epub 2016 Jun 7. Ann Rheum Dis. 2016. PMID: 27269297 No abstract available.

9

Lymphocytic focus score as a prognostic tool.

Risselada AP, Hair Md, Kruize AA, Bijlsma JW, van Roon JA. Risselada AP, et al. Ann Rheum Dis. 2015 Apr;74(4):e31. doi: 10.1136/annrheumdis-2014-207150. Epub 2015 Jan 14. Ann Rheum Dis. 2015. PMID: 25589514 No abstract available.

10

The prognostic value of routinely performed minor salivary gland assessments in primary Sjögren's syndrome.

Risselada AP, Kruize AA, Goldschmeding R, Lafeber FP, Bijlsma JW, van Roon JA. Risselada AP, et al. Ann Rheum Dis. 2014 Aug;73(8):1537-40. doi: 10.1136/annrheumdis-2013-204634. Epub 2014 Feb 13. Ann Rheum Dis. 2014. PMID: 24525912

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results